Advertisement
Screener

BIONIK LABORATORIES CORP. Net Change in Cash

BIONIK LABORATORIES CORP. Net Change in Cash

BIONIK LABORATORIES CORP. reported Net Change in Cash of -$1.56 million for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-21.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-06-21

  • BIONIK LABORATORIES CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-06-30 was -$662.60K.
  • BIONIK LABORATORIES CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-06-30 was -$66.76K, a 150.09% decline year-over-year.
  • BIONIK LABORATORIES CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-06-30 was $133.29K.
  • BIONIK LABORATORIES CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$1.56M, a 213.08% decline from fiscal 2022.
  • BIONIK LABORATORIES CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $1.38M.
  • BIONIK LABORATORIES CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$1.66M.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month
2023-03-31-$1.56M
10-K · filed 2023-06-21
2022-12-31-$1.31M
10-Q · filed 2023-02-08
2022-09-30-$1.59M
10-Q · filed 2022-11-09
2022-06-30-$662.60K
10-Q · filed 2022-08-10
2022-03-31$1.38M
10-K · filed 2023-06-21
2021-12-31$2.76M
10-Q · filed 2023-02-08
2021-09-30$4.17M
10-Q · filed 2022-11-09
2021-06-30-$66.76K
10-Q · filed 2022-08-10
2021-03-31-$1.66M
10-K · filed 2022-06-09
2020-12-31-$1.37M
10-Q · filed 2022-02-09
2020-09-30-$919.12K
10-Q · filed 2021-11-10
2020-06-30$133.29K
10-Q · filed 2021-08-12